AGRX
Agile Therapeutics
AGRX
AGRX
Delisted
AGRX was delisted on the 25th of March, 2024.
45 hedge funds and large institutions have $65.5M invested in Agile Therapeutics in 2017 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 16 increasing their positions, 8 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
15% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 13
41% less capital invested
Capital invested by funds: $111M → $65.5M (-$45.6M)
Holders
45
Holding in Top 10
4
Calls
$288K
Puts
$16K
Top Buyers
| 1 | +$9.09M | |
| 2 | +$964K | |
| 3 | +$867K | |
| 4 |
Renaissance Technologies
New York
|
+$748K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$473K |
Top Sellers
| 1 | -$5.58M | |
| 2 | -$5.45M | |
| 3 | -$1.97M | |
| 4 |
RA
Royce & Associates
New York
|
-$1.73M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$1.62M |